Leading the way to safer medication
 Crosscheck  Recommender

Alendronic acid

Also known as: Alendronate sodium

Description

Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality.

ATC Classification

Code
Title
Category
M05BA04
Alendronic acid
M Musculo-skeletal system → M05 Drugs for treatment of bone diseases → M05B Drugs affecting bone structure and mineralization → M05BA Bisphosphonates

Trade names

Trade name
Countries

Cyprus Singapore United States

France Netherlands

Australia

Australia

Austria Canada France Netherlands Singapore

Cyprus

Singapore

Austria

Austria

France

Trade names (in combination): ADROVANCE ALENCALCI D3 BONENDRO FONATPLUS FOSAMAX PLUS FOSAVANCE VANTAVO

Product Monographs

Monograph
Type
Country
FOSAMAX Once Weekly Tablets
MPI, EU: SmPC
UK